AKCEA THERAPEUTICS, INC. Insider Trading for October 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AKCEA THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AKCEA THERAPEUTICS, INC. for October 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14 2020 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | P | 18.15 | 21,237,715 | 385,464,527 | 98,322,397 | 77.1 M to 98.3 M (+27.55 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | PRICE MICHAEL DENNIS | Chief Financial Off ... | Option Exercise | D | 14.78 | 300,000 | 4,434,000 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | PRICE MICHAEL DENNIS | Chief Financial Off ... | Sell | U | 18.15 | 50,000 | 907,500 | 0 | 50 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Patterson Joshua F. | General Counsel | Option Exercise | D | 12.76 | 7,500 | 95,700 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Patterson Joshua F. | General Counsel | Option Exercise | D | 16.99 | 13,750 | 233,613 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Patterson Joshua F. | General Counsel | Sell | U | 18.15 | 26,532 | 481,556 | 0 | 26.5 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 12.76 | 34,200 | 436,392 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 17.38 | 13,701 | 238,123 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 17.38 | 299 | 5,197 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 12.21 | 32,751 | 399,890 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 12.21 | 143,374 | 1,750,597 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Sell | U | 18.15 | 52,012 | 944,018 | 0 | 52 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Howarth Alex G. | Chief Operating Off ... | Option Exercise | D | 12.76 | 34,200 | 436,392 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Howarth Alex G. | Chief Operating Off ... | Option Exercise | D | 17.94 | 300,000 | 5,382,000 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Howarth Alex G. | Chief Operating Off ... | Sell | U | 18.15 | 66,800 | 1,212,420 | 0 | 66.8 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Andrews William T. | Chief Medical Offic ... | Option Exercise | D | 13.29 | 250,000 | 3,322,500 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Andrews William T. | Chief Medical Offic ... | Sell | U | 18.15 | 37,500 | 680,625 | 0 | 37.5 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | D | 12.76 | 200,000 | 2,552,000 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | D | 12.76 | 120,000 | 1,531,200 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Sell | U | 18.15 | 242,978 | 4,410,051 | 0 | 243 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Yanni Barbara | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | YANG MICHAEL J. | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | D | 12.76 | 200,000 | 2,552,000 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | D | 12.21 | 52,837 | 645,140 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | D | 12.76 | 120,000 | 1,531,200 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Sell | U | 18.15 | 242,978 | 4,410,051 | 0 | 243 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Yanni Barbara | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | YANG MICHAEL J. | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | D | 12.21 | 52,837 | 645,140 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Salzman Amber | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Salzman Amber | Director | Option Exercise | D | 17.94 | 53,000 | 950,820 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | KLEIN JOSEPH III | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Hochberg Elaine | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Hochberg Elaine | Director | Option Exercise | D | 12.21 | 52,837 | 645,140 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | PARSHALL B LYNNE | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 |